OABI
OABI
NASDAQ · Life Sciences Tools & Services

Omniab Inc

$2.48
+0.02 (+0.81%)
As of Jul 4, 2:06 AM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +121.0% upside
Low Target $3.95
Average Target $5.48
High Target $7.31
Current Price $2.48
Current
$2.48
Target
$5.48
$3.95 $5.48 avg $7.31
Scenario Analysis
Bear Case
$3.95
59.3%
Low target
Base Case
$5.48
+121.0%
Avg target
Bull Case
$7.31
+194.8%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$2.79
-11.1% from high
52-Week Low
$1.30
+90.8% from low
Target vs 52W High
$5.48
+96.4% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 85% $369.21 -29.5%
DHR
Danaher Corp
Strong Buy 30 90% $158.11 -20.1%
WAT
Waters Corp
Buy 28 57% $189.60 -50.0%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -50.5%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -59.9%
ILMN
Illumina Inc
Buy 28 61% $169.36 -10.2%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -87.0%
WST
West Pharmaceutical Services
Strong Buy 22 82% $136.24 -62.7%